Perspective Therapeutics (CATX) Institutional Ownership $6.16 -0.62 (-9.14%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Perspective Therapeutics (NYSE:CATX)CurrentInstitutional OwnershipPercentage54.66%Number ofInstitutional Buyers(last 12 months)45TotalInstitutional Inflows(last 12 months)$156.37MNumber ofInstitutional Sellers(last 12 months)16TotalInstitutional Outflows(last 12 months)$642.65M Get CATX Insider Trade Alerts Want to know when executives and insiders are buying or selling Perspective Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CATX Institutional Buying and Selling by Quarter Ad Porter & CompanyThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. Perspective Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC114,075$1.52M0.0%+587.9%0.169% 11/18/2024 JDM Financial Group LLC3,500$47K0.0%-90.0%0.005% 11/16/2024 Geode Capital Management LLC1,164,204$15.55M0.0%+12.5%1.722% 11/15/2024 Barclays PLC114,075$1.52M0.0%+587.9%0.169% 11/15/2024 XTX Topco Ltd37,300$498K0.0%N/A0.055% 11/15/2024 Jane Street Group LLC25,256$337K0.0%-67.9%0.037% Get the Latest News and Ratings for CATX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Perspective Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 Sphera Funds Management LTD.589,295$7.87M1.3%-25.1%0.872% 11/15/2024 State Street Corp2,190,239$29.24M0.0%+119.6%3.240% 11/15/2024 Janus Henderson Group PLC4,799,352$64.01M0.0%+8.0%7.101% 11/15/2024 HighVista Strategies LLC138,350$1.85M0.6%+21.8%0.205% 11/14/2024 Verition Fund Management LLC28,723$383K0.0%N/A0.043% 11/14/2024 Walleye Capital LLC18,117$242K0.0%-96.5%0.027% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC58,678$783K0.0%+5.8%0.087% 11/14/2024 Zurcher Kantonalbank Zurich Cantonalbank 11,378$152K0.0%N/A0.017% 11/14/2024 Ally Bridge Group NY LLC341,739$4.56M2.4%-13.8%0.507% 11/14/2024 MetLife Investment Management LLC31,165$416K0.0%+159.1%0.046% 11/13/2024 BNP Paribas Financial Markets47,565$635K0.0%+1,302.7%0.071% 11/13/2024 FMR LLC5,504,822$73.49M0.0%+3,994.9%8.164% 11/13/2024 The Manufacturers Life Insurance Company 20,514$274K0.0%+8.9%0.030% 11/12/2024 Eagle Asset Management Inc.181,467$2.42M0.0%-24.9%0.269% 11/12/2024 Charles Schwab Investment Management Inc.433,522$5.79M0.0%+221.7%0.643% 11/9/2024 Intech Investment Management LLC10,289$137K0.0%N/A0.015% 11/7/2024 LMR Partners LLP30,000$400K0.0%N/A0.044% 11/6/2024 RIA Advisory Group LLC25,620$342K0.1%N/A0.038% 11/6/2024 CIBC Asset Management Inc19,415$259K0.0%N/A0.029% 11/5/2024 Victory Capital Management Inc.50,460$674K0.0%+328.7%0.075% 11/5/2024 WealthPlan Investment Management LLC339,292$4.53M0.5%N/A0.503% 11/4/2024 Los Angeles Capital Management LLC11,424$153K0.0%N/A0.017% 10/30/2024 AlphaCentric Advisors LLC80,000$1.07M0.8%-2.4%0.128% 10/28/2024 Hills Bank & Trust Co1,027,830$13.72M1.0%N/A1.651% 10/28/2024 US Bancorp DE6,576$88K0.0%+142.7%0.011% 10/24/2024 Taylor & Morgan Wealth Management LLC30,000$400K0.3%N/A0.048% 10/23/2024 Trueblood Wealth Management LLC16,236$217K0.1%N/A0.026% 10/23/2024 Nicholson Wealth Management Group LLC1,602,283$21.39M17.6%N/A2.573% 10/21/2024 Wealth Effects LLC13,250$177K0.1%-23.6%0.021% 10/16/2024 nVerses Capital LLC4,300$57K0.0%N/A0.007% 10/11/2024 Creative Planning41,175$550K0.0%+135.0%0.061% 10/9/2024 Iowa State Bank19,061$254K0.1%N/A0.031% 10/3/2024 SG Americas Securities LLC18,461$246K0.0%N/A0.030% 9/16/2024 Point72 DIFC Ltd11,842$118K0.0%N/A0.018% Election warning coming true… (Ad)If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now.8/19/2024 Point72 Asset Management L.P.202,572$2.02M0.0%-98.5%0.325% 8/15/2024 The Manufacturers Life Insurance Company18,842$188K0.0%N/A0.030% 8/15/2024 Deerfield Management Company L.P. Series C2,817,763$28.09M0.5%-90.0%4.526% 8/15/2024 Affinity Asset Advisors LLC550,000$5.48M0.6%-89.2%0.883% 8/14/2024 Point72 DIFC Ltd11,842$118K0.0%N/A0.019% 8/14/2024 Marshall Wace LLP1,283,942$12.80M0.0%-93.2%2.062% 8/14/2024 Ally Bridge Group NY LLC396,242$3.95M2.4%N/A0.636% 8/14/2024 HighVista Strategies LLC113,550$1.13M0.4%N/A0.182% 8/10/2024 Sofinnova Investments Inc.132,089$1.32M0.1%-69.3%0.212% 8/9/2024 Renaissance Technologies LLC61,660$615K0.0%+94.2%0.099% 8/9/2024 WealthPLAN Partners LLC169,963$1.70M0.2%N/A0.273% 8/9/2024 WINTON GROUP Ltd84,363$841K0.1%N/A0.135% 8/8/2024 Sykon Capital LLC37,932$378K0.1%+4.7%0.061% 8/7/2024 ClariVest Asset Management LLC54,199$540K0.1%N/A0.087% 8/5/2024 Victory Capital Management Inc.11,770$117K0.0%N/A0.019% 8/2/2024 Wealth Effects LLC17,350$173K0.1%-85.2%0.028% 8/1/2024 Rhumbline Advisers63,170$630K0.0%N/A0.101% 7/26/2024 Bank of New York Mellon Corp137,268$1.37M0.0%+214.0%0.220% 7/26/2024 AlphaCentric Advisors LLC82,000$818K0.6%-95.3%0.132% 7/25/2024 AMG National Trust Bank37,330$372K0.0%-90.0%0.060% 5/20/2024Virtu Financial LLC115,762$138K0.0%N/A0.019% 5/16/2024 Janus Henderson Group PLC13,089,476$15.51M0.0%N/A2.230% 5/15/2024 Baker BROS. Advisors LP149,787$178K0.0%-98.0%0.026% 5/15/2024 Affinity Asset Advisors LLC5,100,000$6.07M0.8%N/A0.869% 5/10/2024 Vanguard Group Inc.17,780,106$21.16M0.0%+34.6%3.029% 5/8/2024 Bleakley Financial Group LLC33,570$40K0.0%N/A0.006% 5/3/2024 RIA Advisory Group LLC106,853$127K0.1%+1,313.4%0.018% 4/26/2024 ZWJ Investment Counsel Inc.22,000$26K0.0%N/A0.004% 4/24/2024 Simplicity Wealth LLC33,570$40K0.0%N/A0.006% 1/22/2024 Perkins Capital Management Inc.700,000$281K0.2%-73.8%0.249% 1/11/2024 Taylor & Morgan Wealth Management LLC625,000$251K0.2%+8.7%0.223% 11/8/2023 HighTower Advisors LLC1,147,038$314K0.0%N/A0.409% 11/2/2023 Perkins Capital Management Inc.2,671,644$731K0.7%N/A0.952% 10/24/2023 Bank of New York Mellon Corp154,238$42K0.0%N/A0.055% 10/16/2023 Wealth Effects LLC110,000$30K0.0%N/A0.039% 10/5/2023 Taylor & Morgan Wealth Management LLC575,000$157K0.1%N/A0.205% (Data available from 1/1/2016 forward) CATX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CATX shares? During the previous two years, 60 institutional investors and hedge funds held shares of Perspective Therapeutics. The most heavily invested institutionals were FMR LLC ($73.49M), Janus Henderson Group PLC ($64.01M), State Street Corp ($29.24M), Deerfield Management Company L.P. Series C ($28.09M), Nicholson Wealth Management Group LLC ($21.39M), Vanguard Group Inc. ($21.16M), and Geode Capital Management LLC ($15.55M).Learn more on CATX's institutional investors. What percentage of Perspective Therapeutics stock is owned by institutional investors? 54.66% of Perspective Therapeutics stock is owned by institutional investors. Learn more on CATX's institutional investor holdings. Which institutional investors have been buying Perspective Therapeutics stock? Of the 48 institutional investors that purchased Perspective Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($13.45M), FMR LLC ($5.37M), Affinity Asset Advisors LLC ($5.10M), Vanguard Group Inc. ($4.57M), Perkins Capital Management Inc. ($2.67M), Nicholson Wealth Management Group LLC ($1.60M), and State Street Corp ($1.19M). How much institutional buying is happening at Perspective Therapeutics? Institutional investors have bought a total of 39,762,033 shares in the last 24 months. This purchase volume represents approximately $156.37M in transactions. Which Perspective Therapeutics major shareholders have been selling company stock? Of the 16 institutional investors that sold Perspective Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Deerfield Management Company L.P. Series C ($25.36M), Marshall Wace LLP ($17.69M), Point72 Asset Management L.P. ($13.25M), Baker BROS. Advisors LP ($7.49M), Affinity Asset Advisors LLC ($4.55M), Perkins Capital Management Inc. ($1.97M), and AlphaCentric Advisors LLC ($1.68M). How much institutional selling is happening at Perspective Therapeutics? Institutional investors have sold a total of 73,616,838 shares in the last 24 months. This volume of shares sold represents approximately $642.65M in transactions. Related Companies TNDM Major Shareholders RXST Major Shareholders NVCR Major Shareholders INMD Major Shareholders MDXG Major Shareholders AORT Major Shareholders ESTA Major Shareholders PLSE Major Shareholders BLFS Major Shareholders BVS Major Shareholders This page (NYSE:CATX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Perspective Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Perspective Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
